Balthaser Kevin

Track

Insider profile

Performance

Overall performance
1.5
Performance over holding periods
1.5
30 days 90 days 120 days
Average return -10% 8.2% 15.1%
Success rate 24% 68% 82%
Transactions
3 33% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Balthaser Kevin's trades of Aclaris Therapeutics Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Purchase
Price
63.03
Quantity 34,708 +39.5%
Value US$707,085
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2023-09-07 2023-09-06
B Purchase
34,708 +39.5%
63.03
US$707,085 		34,708 +39.5% 63.03 US$707,085
2023-03-03 2023-03-03
S Sale
48,003 -33.0%
296.87
US$4,404,649 		48,003 -33.0% 296.87 US$4,404,649
2023-03-03 2023-03-02
S Sale
95,676 +0.9%
249.88
US$3,700,549 		95,676 +0.9% 249.88 US$3,700,549